How to adjust metabolic rate (MR) in mice that differ in body mass and composition continues to lead to controversies. Here, the challenges that reside in the analysis of mouse MR are highlighted to spur consensus on the unequivocal use of regression-based analysis to maximize reliability and relevance of conclusions.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Activation of GPR81 by lactate drives tumour-induced cachexia
Nature Metabolism Open Access 18 March 2024
-
SLC35D3 promotes white adipose tissue browning to ameliorate obesity by NOTCH signaling
Nature Communications Open Access 23 November 2023
-
Sex-specific effects of Cre expression in Syn1Cre mice
Scientific Reports Open Access 20 June 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
08 October 2021
A Correction to this paper has been published: https://doi.org/10.1038/s42255-021-00485-6
References
Tschop, M. H. et al. Nat. Methods 9, 57–63 (2011).
Fernandez-Verdejo, R., Ravussin, E., Speakman, J. R. & Galgani, J. E. Nat. Methods 16, 797–799 (2019).
Packard, G. C. & Boardman, T. J. Comp. Biochem. Physiol. A 122, 37–44 (1999).
Speakman, J. R., Fletcher, Q. & Vaanholt, L. Dis. Model Mech. 6, 293–301 (2013).
Ravussin, E. & Bogardus, C. Am. J. Clin. Nutr. 49, 968–975 (1989).
Tanner, J. M. J. Appl. Physiol. 2, 1–15 (1949).
Weil, W. B. Jr Am. J. Clin. Nutr. 11, 249–252 (1962).
Packard, G. C. & Boardman, T. J. Physiol. Zool. 61, 1–9 (1988).
Mina, A. I. et al. Cell. Metab. 28, 656–666 (2018).
Kless, C., Rink, N., Rozman, J. & Klingenspor, M. Eur. J. Clin. Nutr. 71, 306–317 (2017).
Acknowledgements
This study was supported in part by funding from the German Research Foundation (DFG) TRR152 and TRR296, the European Research Council ERC AdG HypoFlam no. 695054 and the German Center for Diabetes Research (DZD e.V).
Author information
Authors and Affiliations
Contributions
T.D.M., M.K. and M.H.T. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
M.H.T. is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, MA, USA. He was a member of the Research Cluster Advisory Panel (ReCAP) of the Novo Nordisk Foundation between 2017 and 2019. He attended a scientific advisory board meeting of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, in 2016. He received funding for his research projects by Novo Nordisk (2016-2020) and Sanofi-Aventis (2012–2019). He was a consultant for Bionorica SE (2013–2017), Menarini Ricerche S.p.A. (2016) and Bayer Pharma AG Berlin (2016). As former director of the Helmholtz Diabetes Center and the Institute for Diabetes and Obesity at Helmholtz Zentrum München (2011–2018), and since 2018, as CEO of Helmholtz Zentrum München, M.H.T. has been responsible for collaborations with a multitude of companies and institutions worldwide. In this capacity, he discussed potential projects with and signed contracts for his institute(s) and the staff for research funding and/or collaborations with industry and academia worldwide, including but not limited to pharmaceutical corporations such as Boehringer Ingelheim, Eli Lilly, Novo Nordisk, MediGene, Arbormed, BioSyngen and others. In this role, he was/is further responsible for commercial technology transfer activities of his institute(s), including diabetes-related patent portfolios of Helmholtz Zentrum München such as WO/2016/188932 A2 and WO/2017/194499 A1. M.H.T. confirmed that to the best of his knowledge, none of the funding sources were involved in preparing this paper. T.D.M. receives research funding by Novo Nordisk, but these funds were unrelated to the work described herein. M.K. declares no competing interests.
Additional information
Peer review information Nature Metabolism thanks Joerg Heeren for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Müller, T.D., Klingenspor, M. & Tschöp, M.H. Revisiting energy expenditure: how to correct mouse metabolic rate for body mass. Nat Metab 3, 1134–1136 (2021). https://doi.org/10.1038/s42255-021-00451-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-021-00451-2
This article is cited by
-
Activation of GPR81 by lactate drives tumour-induced cachexia
Nature Metabolism (2024)
-
mTORC1 in energy expenditure: consequences for obesity
Nature Reviews Endocrinology (2024)
-
The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice
Obesity Surgery (2024)
-
Sex-specific effects of Cre expression in Syn1Cre mice
Scientific Reports (2023)
-
Hypothalamic Grb10 enhances leptin signalling and promotes weight loss
Nature Metabolism (2023)